ENTX Entera Bio Ltd

Entera Bio Ltd is a biotechnology company specializing in the oral delivery of large molecules and biologics. It conducts clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics.

$3.34
As of 11/30/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  06/29/2018
Outstanding shares:  23,738,642
Average volume:  72,956
Market cap:   $81,423,542
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    293850103
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -4.16
PB ratio:   3.75
PS ratio:   129.86
Return on equity:   -74.49%
Net income %:   -3,086.76%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy